Massachusetts Financial Services
DNA icon

Massachusetts Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Massachusetts Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Sell
47,090
-1,877
-4% -$15.7K ﹤0.01% 954
2026
Q1 		$300K Sell
48,967
-1,306
-3% -$10.9K ﹤0.01% 921
2025
Q4 		$418K Buy
50,273
+20,005
+66% +$215K ﹤0.01% 882
2025
Q3 		$441K Buy
+30,268
New +$362K ﹤0.01% 835

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Massachusetts Financial Services's DNA Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Ginkgo Bioworks (DNA) stake by 3.8% in Q2 2026, selling an estimated $15.7K and leaving 47,090 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #954.

Massachusetts Financial Services first reported a position in DNA in Q3 2025 and has held it in 4 quarters since. 67 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Massachusetts Financial Services held 47,090 shares of Ginkgo Bioworks worth $467K as of Q2 2026.
  • Massachusetts Financial Services sold 1,877 Ginkgo Bioworks shares in Q2 2026, an estimated $15.7K.
  • Ginkgo Bioworks made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #954 holding.
  • Massachusetts Financial Services first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 4 quarters since.
  • 67 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.